MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.
about
Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisNon-invasive quantification of collagen turnover in renal transplant recipientsMMP-9 expression varies according to molecular subtypes of breast cancer.Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.Accelerated extracellular matrix turnover during exacerbations of COPD.Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis.Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer.CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasisHigh levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.Collapsed Reticular Network and its Possible Mechanism during the Initiation and/or Progression of Hepatic FibrosisFacts and promises on lung biomarkers in interstitial lung diseases.Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.The minor collagens in articular cartilage.Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer.Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation.In Situ Imaging of Tissue Remodeling with Collagen Hybridizing Peptides.A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiologyMMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer.Orthodontic tensile strain induces angiogenesis via type IV collagen degradation by matrix metalloproteinase-12.Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix.A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia.Tumstatin, a Matrikine Derived from Collagen Type IVα3, is Elevated in Serum from Patients with Non-Small Cell Lung Cancer.Cardiac magnetic resonance using late gadolinium enhancement and atrial T1 mapping predicts poor outcome in patients with atrial fibrillation after catheter ablation therapyNo effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trialAn Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
P2860
Q28386047-814F1906-D380-4AC8-B367-309647A01180Q33590296-303C0922-DDCE-4CA6-9B92-45ECBC146326Q34116451-C1A2D6FE-4C61-4D47-A159-749BFC184295Q34463741-0B138D66-CC15-44B7-B334-DADB21D85165Q35816871-D84ACA19-76B0-4EA5-8D8D-77F8BDC2F882Q35963115-21D70AA9-B233-401E-B601-3D9A04BCAB17Q36538088-BE466FD2-57F5-45A5-A5C9-135666CC682EQ36640681-C580F5C2-A6EF-4158-85D8-C3CD0C246940Q37046438-449B8130-7022-42EC-B1F2-501C1DAE486CQ37311290-5BD8DDEF-458D-4D99-A787-0A9B6DB17727Q37339900-FBDDF83D-E7A8-47F1-8D81-1BE9681CB88CQ38543042-360DCA00-91A4-48A2-8998-96E005B9AA06Q38675211-46080DDE-F897-402C-ADB4-922FDC8B3CD9Q38811356-7F132223-74FE-4CC8-A17C-59DA473C27D8Q39141588-D0C51BFC-3A26-4128-B0D0-CBC56D38A138Q41592769-19E43F07-78BB-4147-9723-18A91241CED9Q42411948-F0AA8E5B-BF60-4388-A250-2C576110334CQ42628541-F968A4A1-F39B-4E27-AB61-F4122E9E9D77Q42702771-A1E2B209-5E8D-47AE-A531-B74EC5D9CCBCQ47104693-AC424177-B223-4F7E-99BA-6F8293803F75Q47833851-D0357A60-198E-44B5-BC09-49DF48572F9AQ52806365-403ED96F-E904-4723-A8C7-FF29DC58BEADQ55262276-23F84A13-358F-4B9A-9734-81A0A014DDDCQ55307827-074E242F-D019-43FB-9AA4-EFA56B54F61CQ58751785-6E5DE752-01B5-46D4-8300-5A23D78F3A18Q58763693-2EB010FD-53D8-445F-BBC7-E1CFDAD12151Q58771253-0F399B37-8FF9-4235-B7D5-1CDF3ADCC80F
P2860
MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MMP mediated degradation of ty ...... of two novel biomarker assays.
@ast
MMP mediated degradation of ty ...... of two novel biomarker assays.
@en
type
label
MMP mediated degradation of ty ...... of two novel biomarker assays.
@ast
MMP mediated degradation of ty ...... of two novel biomarker assays.
@en
prefLabel
MMP mediated degradation of ty ...... of two novel biomarker assays.
@ast
MMP mediated degradation of ty ...... of two novel biomarker assays.
@en
P2093
P2860
P1433
P1476
MMP mediated degradation of ty ...... of two novel biomarker assays.
@en
P2093
Arkadiusz Nawrocki
Cory Hogaboam
Diana Julie Leeming
Fernando Martinez
Lise Larsen
Meilan Han
Morten Asser Karsdal
Qinlong Zheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0084934
P407
P577
2013-12-23T00:00:00Z